News

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.

We know

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.

We know

Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in the near-term. And out of all of the

Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks

Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks

Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in the near-term. And out of all of the

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among

Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure

While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure

Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among

While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure

Shares of Moderna MRNA rose 13% in the past week after the company announced preliminary sales for the full-year 2025, as well as business outlook for 2026 and beyond. It also outlined some expected

Electric vehicle (EV) giant Tesla TSLA is making a major change to how it sells Full Self-Driving (FSD). The company will stop offering FSD as a one-time purchase after Feb. 14, 2026. Instead, FSD

Shares of Argan, Inc. AGX have surged 49% in the past six months, well above the Zacks Building Products - Miscellaneous industry’s 18.2% growth. The stock has further outperformed the broader Const

Ingevity Corporation’s NGVT shares have gained 18.7% over the past three months. The company has also outperformed the Zacks Chemical - Specialty industry’s 4.8% growth and the S&P 500’s 6.3%

There are several different ways to find value stocks. Among these, the most popular are the price-to-earnings ratio (P/E) and the price-to-sales ratio (P/S). However, investors often overlook the

U.S. Bancorp USB entered a definitive agreement to acquire BTIG, LLC for $1 billion. This stock and cash transaction will likely be closed in the second quarter, subject to regulatory approvals and

Petrobras PBR, Brazil's state-controlled oil and gas giant, recently marked a significant milestone in its ongoing efforts to revitalize the oil production capabilities. According to Reuters, as

BASF SE’s BASFY Agricultural Solutions unit signed an agreement to acquire AgBiTech from private equity firm Paine Schwartz Partners and other shareholders. AgBiTech specializes in biological insect